ACTIVE HALF-LIFE
12-36 hours
CLASSIFICATION
Peptide Hormone
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
IBSA
WAREHOUSE
International Warehouse 2
SUBSTANCE
Human Menopausal Gonadotropin
,
Merional 75IU, also known as hMG or Menotropin, is utilized for treating infertility in women. This hormonally active medication promotes egg production in the ovaries for those experiencing ovarian failure. The Merional 75IU Injection is derived from the urine of postmenopausal women, which contains elevated amounts of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and gonadotropins. This injection is administered intramuscularly.
Potential side effects of the Merional 75IU Injection include headaches, mood fluctuations, fatigue, weight gain, localized swelling at the injection site, breast enlargement, and tenderness. A common adverse effect is abdominal pain due to ovarian hyperstimulation syndrome (OHSS), which can occur if too many eggs are produced, leading to ovarian swelling. Another concern is the possibility of conceiving twins unintentionally. Before starting this medication, it is essential to consult your doctor and disclose if you have any of the following conditions:
Dosage varies among individuals and is tailored to each patient’s needs. For optimal chances of conception, it is recommended to have intercourse 12 to 36 hours after receiving the Merional 75IU Injection. If the initial treatment cycle is unsuccessful, it may be necessary to reassess the situation. You should reconsider the use of Merional 75IU Injection and consult your doctor if ovulation does not occur after three treatment cycles.